{"gene":"STAR","run_date":"2026-06-10T07:46:42","timeline":{"discoveries":[{"year":2001,"finding":"StAR protein mediates the rate-limiting step in steroidogenesis by transferring cholesterol from the outer to the inner mitochondrial membrane, where the cholesterol side-chain cleavage enzyme (P450scc) converts it to pregnenolone. StAR acts exclusively on the outer mitochondrial membrane, and its import into mitochondria is not essential for activity but rather represents a means of inactivating it.","method":"Genetic analysis of congenital lipoid adrenal hyperplasia mutations, StAR null mouse phenotype, functional complementation in COS-1 cells, recombinant protein studies on isolated mitochondria","journal":"Annual review of physiology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods across multiple labs: reconstitution in engineered cells, mutagenesis, genetic disease validation, null mouse model","pmids":["11181954"],"is_preprint":false},{"year":1998,"finding":"Recombinant StAR protein (lacking the N-terminal 62 aa mitochondrial targeting sequence) stimulates transfer of cholesterol and beta-sitosterol from liposomes to heat-treated mitochondria in a dose-, time-, and temperature-dependent manner, demonstrating sterol transfer activity. A non-functional StAR mutant did not promote sterol transfer. Unlike SCP2, StAR did not stimulate phosphatidylcholine transfer, indicating sterol selectivity.","method":"In vitro sterol transfer assay using recombinant proteins, liposomes, and heat-treated mitochondria; site-directed mutagenesis of non-functional StAR","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with recombinant protein, mutagenesis controls, and multiple substrates tested","pmids":["9756854"],"is_preprint":false},{"year":1999,"finding":"StAR is a target for serine phosphorylation by protein kinase A (PKA) at S194/195 (mouse/human), and this phosphorylation is required for maximizing StAR steroidogenic activity. Import into mitochondria inactivates StAR; the C-terminus contains the functionally important domains for steroidogenic activity.","method":"Truncation mutations, site-directed mutagenesis, functional assays in steroidogenic cells, phosphorylation studies","journal":"Recent progress in hormone research","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — mutagenesis of phosphorylation sites combined with functional steroidogenesis assays, replicated across multiple studies","pmids":["10548884"],"is_preprint":false},{"year":1997,"finding":"Steroidogenic factor 1 (SF-1) is required for StAR gene transcription. The human StAR promoter contains two cis elements (distal and proximal) governing basal and cAMP-regulated expression; the distal element is a high-affinity SF-1 binding site. Cotransfection of SF-1 allows StAR promoter function in BeWo cells that normally lack activity; deletion or mutation of either element substantially reduces SF-1-supported activity.","method":"Promoter-luciferase reporter assays, cotransfection with SF-1 expression plasmid, deletion and site-directed mutation of cis elements, gel shift / binding assays","journal":"Steroids","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — promoter deletion/mutation combined with cotransfection rescue, binding assays, multiple orthogonal methods","pmids":["9029708"],"is_preprint":false},{"year":1996,"finding":"StAR mRNA and protein are expressed in the most steroidogenic compartments of the human ovary (theca of preovulatory follicles, luteinized granulosa and thecal cells). cAMP analog 8-Br-cAMP increases StAR mRNA by increasing StAR gene transcription (not mRNA stability). Phorbol myristate acetate (protein kinase C activator) antagonizes the cAMP stimulatory effect on StAR expression.","method":"In situ hybridization, Northern blot, nuclear run-on transcription assays, mRNA stability assays, promoter-luciferase transfection in granulosa-lutein cells","journal":"The Journal of clinical endocrinology and metabolism","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (transcription run-on, stability assay, reporter assay) in primary human cells","pmids":["8923870"],"is_preprint":false},{"year":2007,"finding":"StAR's interaction with protonated phospholipid head groups on the outer mitochondrial membrane induces a molten globule conformational change required for its cholesterol transfer activity. StAR requires cholesterol binding and acts on the outer membrane. A model is proposed wherein StAR removes cholesterol from the cholesterol-binding domain of the peripheral benzodiazepine receptor (PBR) and delivers it to the inner mitochondrial membrane.","method":"Biophysical spectroscopy, molecular dynamics simulations, structure-function studies in synthetic and natural membranes","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — biophysical and simulation data from single lab, mechanistic model supported by multiple orthogonal methods but not fully reconstituted biochemically","pmids":["17433772"],"is_preprint":false},{"year":2007,"finding":"StAR acts on the outer mitochondrial membrane, requires cholesterol binding, and requires a pH-dependent molten globule structural change for function. Functional interaction between StAR and PBR (peripheral benzodiazepine receptor) is indicated.","method":"Structure-function analysis, biophysical studies, outer membrane activity assays","journal":"Molecular and cellular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple biophysical and functional assays from single lab","pmids":["17207924"],"is_preprint":false},{"year":2002,"finding":"PBR (peripheral benzodiazepine receptor), StAR, and PKA cooperate in hormone-induced mitochondrial cholesterol transport. PAP7, a protein that interacts with both PBR and the PKA regulatory subunit RIα, is present in mitochondria of adrenal and gonadal cells; overexpression of PAP7 increases hormone-induced steroid production, and inhibition of PAP7 reduces it, indicating PAP7 bridges PKA to PBR-StAR complex.","method":"Antisense oligonucleotide knockdown, co-immunoprecipitation/protein interaction studies, overexpression, steroid production assays in MA-10 Leydig cells","journal":"Endocrine research","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — reciprocal protein interaction and functional rescue data, but single lab with limited mechanistic resolution","pmids":["12530641"],"is_preprint":false},{"year":2014,"finding":"ERK1/2 phosphorylates StAR, and this phosphorylation regulates StAR retention on the outer mitochondrial membrane (OMM) and StAR activity. Mitochondrial fusion also plays a role in regulating StAR retention on the OMM, thereby modulating its steroidogenic activity.","method":"Phosphorylation assays, kinase inhibitor experiments, mitochondrial fractionation, functional steroidogenesis assays","journal":"Molecular and cellular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — phosphorylation and functional assays in single lab with multiple approaches","pmids":["25540920"],"is_preprint":false},{"year":2007,"finding":"Once synthesized on free polyribosomes, StAR preprotein either associates with the outer mitochondrial membrane to mediate cholesterol transfer, or is degraded by the proteasome. Upon mitochondrial import, StAR is subject to rapid turnover: one pool is degraded by matrix proteases shortly after import; a second pool undergoes slower degradation after translocation to the matrix face of the inner membrane. Proteasome inhibitors (MG132, clasto-lactacystin beta-lactone but not epoxomicin) can inhibit turnover of both cytoplasmic preprotein and intra-mitochondrial StAR.","method":"Proteasome inhibitor treatment, immuno-electron microscopy, pulse-chase protein turnover assays, mitochondrial fractionation","journal":"Molecular and cellular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (immuno-EM, fractionation, pharmacological inhibition) from single lab","pmids":["17218054"],"is_preprint":false},{"year":2008,"finding":"Photoaffinity labeling with [(3)H]azocholestanol predominantly labeled a 6.2 kDa fragment (amino acids 83-140) of STARD1-START, which contains residues proposed to interact with cholesterol in a hydrophobic cavity. Cholesterol preferentially interacts with one side wall of this cavity. By contrast, cholesterol had no protective effect against trypsin degradation of STARD1-START (unlike STARD3), suggesting differential cholesterol-binding properties between the two START domains.","method":"Photoaffinity labeling with radiolabeled azocholestanol, trypsin protection assays, peptide mapping","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — direct photoaffinity labeling and peptide mapping identify cholesterol-binding region, single lab","pmids":["18331352"],"is_preprint":false},{"year":2008,"finding":"NMR studies of StAR in apo- and holo-states at physiological pH show well-dispersed resonances with key spectral differences between states, consistent with a two-state model in which the C-terminal alpha-helix undergoes partial unfolding (molten globule transition) to allow cholesterol binding, followed by stabilization and refolding upon cholesterol binding. This structural gating mechanism is proposed for cholesterol access.","method":"Solution-state NMR ((1)H-(15)N-HSQC), homology modeling, structure-based thermodynamics","journal":"Molecular and cellular endocrinology","confidence":"Low","confidence_rationale":"Tier 2 / Weak — NMR data consistent with model but full structure not solved; single lab, no mutagenesis validation in this paper","pmids":["19138724"],"is_preprint":false},{"year":2007,"finding":"TORC (transducer of regulated CREB activity), a CREB coactivator, regulates StAR gene expression: dephosphorylated TORC is active and promotes StAR transcription. PKA phosphorylates CREB and simultaneously inhibits TORC kinases, leading to TORC dephosphorylation and activation. Staurosporine (kinase inhibitor) increases dephospho-TORC and induces StAR expression in Y1 adrenocortical cells.","method":"Pharmacological inhibition (staurosporine, KG501), reporter gene assays, phosphorylation analysis, expression studies in Y1 adrenocortical cells","journal":"Molecular and cellular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological and reporter assays with mechanistic logic linking PKA to TORC dephosphorylation and StAR transcription, single lab","pmids":["17210223"],"is_preprint":false},{"year":2019,"finding":"Endoplasmic reticulum (ER) stress induces STARD1 upregulation in hepatocytes, which mediates mitochondrial cholesterol accumulation, sustained mitochondrial GSH depletion, and mitochondrial dysfunction leading to acetaminophen-induced acute liver failure. Liver-specific STARD1 deletion (Stard1ΔHep) protected mice from APAP/VPA-induced ALF despite increased mitochondrial GSH and phosphorylated JNK. STARD1 acts upstream of SAB (SH3BP5) and JNK1/2 phosphorylation in this hepatotoxicity pathway.","method":"Liver-specific conditional knockout mice (Stard1ΔHep, SabΔHep, Jnk1+2ΔHep), pharmacological ER stress inhibition (TUDCA), histology, mitochondrial function assays, humanized liver mouse model (FRGN)","journal":"Gastroenterology","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO of multiple pathway components with epistasis analysis, replicated in humanized liver model, multiple orthogonal readouts","pmids":["31029706"],"is_preprint":false},{"year":2021,"finding":"STARD1 promotes generation of primary bile acids (β-muricholic acid, cholic acid and their tauroconjugates) through the alternative mitochondrial pathway in hepatocytes. STARD1 overexpression in NASH mouse models increases liver tumor multiplicity, while hepatocyte-specific STARD1 deletion reduces tumor burden. The STARD1-generated bile acids act on tumor-initiated stem-like cells (TICs) to stimulate stemness, pluripotency and inflammation, linking STARD1 to HCC pathogenesis.","method":"Hepatocyte-specific STARD1 deletion (Stard1ΔHep) and overexpression in NASH-HCC mouse models, bile acid profiling by mass spectrometry, TIC and primary hepatocyte incubation assays","journal":"Journal of hepatology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic gain- and loss-of-function in multiple mouse models, mass spectrometry quantification, cell-based functional validation","pmids":["33515644"],"is_preprint":false},{"year":2019,"finding":"HIF-1 (hypoxia-inducible factor 1) directly binds to the StAR/STAR promoter at three specific binding sites (-2082/-2078, -2064/-2060, -1910/-1906) and represses STAR transcription, leading to reduced cholesterol transport and decreased testosterone synthesis in Leydig cells. This was shown to specifically affect cholesterol transport (blocked by pregnenolone rescue but not cAMP), while other steroidogenic enzymes (3b-HSD, 17b-HSD, P450scc) were not significantly affected.","method":"ChIP, EMSA supershift, dual-luciferase reporter assay, site-directed mutation of HIF-1 binding sites, hypoxia exposure in vivo (mice) and in vitro (rat primary Leydig cells, TM3 cells)","journal":"Journal of molecular endocrinology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — ChIP, EMSA, reporter assay with mutation analysis, in vivo and in vitro validation across multiple orthogonal methods","pmids":["30400066"],"is_preprint":false},{"year":2017,"finding":"StAR is a novel target of the microRNA let-7, which inhibits StAR at the post-transcriptional level. The long noncoding RNA H19 stimulates StAR expression by sponging/antagonizing let-7, thereby relieving let-7-mediated repression of StAR.","method":"Overexpression of H19 and let-7, reporter assays, murine and human cell line experiments","journal":"Endocrinology","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — overexpression and reporter assays in cell lines, single lab, two cell systems tested","pmids":["27813675"],"is_preprint":false},{"year":2021,"finding":"STAR knockout in MA-10 mouse Leydig cells abolishes progesterone formation in response to dibutyryl-cAMP and TSPO drug ligands (but not to the membrane-permeable 22(R)-hydroxycholesterol). STAR KO cells show significantly altered lipid droplet density and composition, with marked increases in diacylglycerol (DAG, particularly DAG 38:1), cholesteryl ester, and phosphatidylcholine in lipid droplets, suggesting constitutive STAR has a role in DAG accumulation in lipid droplets beyond cholesterol transport.","method":"CRISPR/Cas9 STAR knockout in MA-10 cells, steroid production assays, electron microscopy, liquid chromatography-mass spectrometry of lipid droplet content, transcriptomic analysis","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO with multiple orthogonal readouts (steroidogenesis, EM, lipidomics) in single lab","pmids":["33670702"],"is_preprint":false},{"year":2021,"finding":"Acid ceramidase (ACDase) inversely regulates STARD1 expression: reduced ACDase in NPC disease correlates with increased STARD1 and mitochondrial cholesterol. Transfection of ACDase in NPC patient fibroblasts decreased STARD1 expression and mitochondrial cholesterol accumulation, resulting in increased mitochondrial GSH, improved mitochondrial function, and decreased oxidative stress. The STARD1 upregulation in NPC is dissociated from ER stress and linked to LRH-1 levels.","method":"U18666A treatment in Stard1f/f and Stard1ΔHep mice, ACDase transfection in NPC patient fibroblasts, mitochondrial cholesterol measurement, GSH assay, mitochondrial functional assays","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic and rescue experiments with mechanistic readouts, single lab, multiple cell/model systems","pmids":["34175669"],"is_preprint":false},{"year":2017,"finding":"StAR overexpression in a high-fat diet NAFLD mouse model reduced hepatic lipid accumulation and attenuated insulin resistance through activation of the farnesoid X receptor (FXR) and reduction of intracellular diacylglycerol levels with consequent decreased PKCε phosphorylation. FXR inactivation reversed these beneficial effects of StAR overexpression.","method":"Recombinant adenovirus-mediated StAR overexpression in HFD mice and FFA-overloaded hepatocytes, lipid measurement, insulin signaling assays, FXR inhibition experiments","journal":"Biochimica et biophysica acta. Molecular basis of disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function with pathway rescue (FXR inhibition), in vivo and in vitro, single lab","pmids":["28153708"],"is_preprint":false},{"year":2016,"finding":"ACTH activates StAR through the cAMP-PKA signaling pathway. PKA-dependent phosphorylation of StAR at S194/195 (mouse/human) is required for StAR function. The current model places StAR translation and phosphorylation at the outer mitochondrial membrane as the site of StAR action.","method":"Review/synthesis of mutagenesis and phosphorylation studies; the mechanistic conclusions are grounded in cited primary experimental work on PKA phosphorylation and site-directed mutants","journal":"Frontiers in neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — synthesizes established mutagenesis and signaling data, but this specific paper is a review rather than primary experimental work","pmids":["27999527"],"is_preprint":false}],"current_model":"STAR/STARD1 is a mitochondrial cholesterol transfer protein that acts on the outer mitochondrial membrane to facilitate the rate-limiting transport of cholesterol from the outer to the inner mitochondrial membrane for steroid hormone biosynthesis; it functions via a pH-dependent molten globule conformational change, requires PKA-mediated phosphorylation at S194/195 for maximal activity, is transcriptionally regulated by SF-1/NR5A, CREB/TORC, and HIF-1, post-transcriptionally regulated by the H19/let-7 axis, and has additional roles in hepatic bile acid synthesis, mitochondrial cholesterol homeostasis in liver disease, and diacylglycerol metabolism in Leydig cells."},"narrative":{"mechanistic_narrative":"STAR (STARD1) mediates the rate-limiting step of steroidogenesis by transferring cholesterol from the outer to the inner mitochondrial membrane, where P450scc converts it to pregnenolone [PMID:11181954]. It is a sterol-selective transfer protein: recombinant StAR moves cholesterol and beta-sitosterol—but not phosphatidylcholine—from liposomes to mitochondria, and a non-functional mutant fails to do so [PMID:9756854]. StAR acts on the cytosolic face of the outer mitochondrial membrane, where interaction with protonated phospholipid head groups drives a pH-dependent molten-globule conformational transition; the partially unfolded C-terminal helix opens a hydrophobic cavity (residues ~83–140) that binds cholesterol [PMID:17433772, PMID:18331352, PMID:19138724]. Import into the mitochondrial matrix terminates StAR activity and targets it for turnover by matrix proteases and the proteasome, so activity is intrinsically coupled to its residence at the outer membrane [PMID:11181954, PMID:17218054]. StAR function is gated by phosphorylation: PKA phosphorylates S194/195 downstream of ACTH/cAMP signaling to maximize steroidogenic activity, while ERK1/2 phosphorylation and mitochondrial fusion control StAR retention at the outer membrane [PMID:10548884, PMID:25540920, PMID:27999527]. Cholesterol delivery is organized within an outer-membrane complex involving the peripheral benzodiazepine receptor (PBR/TSPO), with PAP7 bridging PKA (RIα) to the PBR-StAR machinery [PMID:17433772, PMID:12530641]. STAR transcription is controlled by SF-1/NR5A acting at the proximal and distal promoter elements and by cAMP-driven CREB/TORC signaling, and is directly repressed by HIF-1 under hypoxia, while the H19/let-7 axis tunes StAR post-transcriptionally [PMID:9029708, PMID:8923870, PMID:17210223, PMID:30400066, PMID:27813675]. Beyond steroidogenesis, STARD1 governs mitochondrial cholesterol homeostasis in hepatocytes: it is induced by ER stress to drive mitochondrial cholesterol loading and GSH depletion in acetaminophen-induced liver failure [PMID:31029706], supplies cholesterol for primary bile acid synthesis via the alternative pathway and thereby promotes NASH-driven hepatocarcinogenesis [PMID:33515644], and also influences hepatic lipid metabolism and diacylglycerol accumulation [PMID:33670702, PMID:28153708]. Genetic analysis of congenital lipoid adrenal hyperplasia mutations and the StAR-null mouse established its essential role in steroid hormone biosynthesis [PMID:11181954].","teleology":[{"year":1996,"claim":"Established that StAR expression is concentrated in the most steroidogenic cells and is controlled at the transcriptional level by cAMP, defining the regulatory logic of acute steroidogenesis.","evidence":"In situ hybridization, nuclear run-on and reporter assays in primary human ovarian/granulosa-lutein cells","pmids":["8923870"],"confidence":"High","gaps":["Did not identify the transcription factors mediating cAMP responsiveness","Did not address protein-level mechanism of cholesterol transfer"]},{"year":1997,"claim":"Identified SF-1 as the transcription factor required for StAR promoter activity, providing the molecular link between steroidogenic cell identity and StAR expression.","evidence":"Promoter-luciferase reporter assays, SF-1 cotransfection rescue in BeWo cells, cis-element deletion/mutation and binding assays","pmids":["9029708"],"confidence":"High","gaps":["Did not resolve how cAMP signaling converges on the promoter","Other promoter regulators not characterized"]},{"year":1998,"claim":"Demonstrated directly that StAR is a sterol-selective transfer protein, answering whether StAR itself moves cholesterol rather than merely regulating another carrier.","evidence":"In vitro sterol transfer assay with recombinant StAR, liposomes, heat-treated mitochondria, with a non-functional mutant control and phosphatidylcholine selectivity test","pmids":["9756854"],"confidence":"High","gaps":["Did not define the membrane on which StAR acts in cells","Structural basis of cholesterol selectivity not resolved"]},{"year":1999,"claim":"Showed PKA phosphorylation at S194/195 maximizes StAR activity and that mitochondrial import inactivates it, establishing that StAR acts before/at the outer membrane and is post-translationally gated.","evidence":"Truncation and site-directed mutagenesis with functional steroidogenesis and phosphorylation assays","pmids":["10548884"],"confidence":"High","gaps":["Mechanism by which phosphorylation enhances activity not defined","Did not establish the structural change underlying activity"]},{"year":2001,"claim":"Synthesized genetic and biochemical evidence to fix the canonical model: StAR mediates the rate-limiting outer-to-inner membrane cholesterol transfer feeding P450scc, validated by congenital lipoid adrenal hyperplasia and the null mouse.","evidence":"Congenital lipoid adrenal hyperplasia mutation analysis, StAR-null mouse phenotype, COS-1 complementation, recombinant protein on isolated mitochondria","pmids":["11181954"],"confidence":"High","gaps":["Molecular machinery transferring cholesterol across the intermembrane space not fully defined","Outer-membrane partner proteins not yet identified"]},{"year":2002,"claim":"Placed StAR within an outer-membrane signaling-transport complex by showing PAP7 bridges PKA (RIα) to PBR, coupling hormone signaling to cholesterol import.","evidence":"Antisense knockdown, co-IP/interaction studies, overexpression and steroid assays in MA-10 Leydig cells","pmids":["12530641"],"confidence":"Medium","gaps":["Direct StAR-PBR physical contact not biochemically resolved","Single lab, limited mechanistic resolution"]},{"year":2007,"claim":"Defined the conformational mechanism of StAR action—a pH/phospholipid-induced molten-globule transition at the outer membrane required for cholesterol transfer, with a proposed StAR-PBR cholesterol handoff.","evidence":"Biophysical spectroscopy, molecular dynamics, structure-function studies in synthetic and natural membranes (two complementary studies)","pmids":["17433772","17207924"],"confidence":"Medium","gaps":["Not reconstituted as a complete biochemical pathway","Direct cholesterol transfer from PBR to inner membrane not demonstrated"]},{"year":2007,"claim":"Resolved StAR turnover dynamics, showing the cytoplasmic preprotein partitions between outer-membrane activity and proteasomal/matrix-protease degradation, mechanistically explaining why import inactivates StAR.","evidence":"Proteasome inhibitor treatment, immuno-EM, pulse-chase turnover, mitochondrial fractionation","pmids":["17218054"],"confidence":"Medium","gaps":["E3 ligase / degradation signal not identified","Quantitative flux between active and degraded pools not defined"]},{"year":2007,"claim":"Connected cAMP signaling to StAR transcription beyond SF-1 by showing the CREB coactivator TORC is activated by PKA-driven dephosphorylation to promote StAR expression.","evidence":"Pharmacological inhibition, reporter assays and phosphorylation analysis in Y1 adrenocortical cells","pmids":["17210223"],"confidence":"Medium","gaps":["TORC binding to the StAR promoter not directly mapped","Single lab pharmacological approach"]},{"year":2008,"claim":"Localized the cholesterol-binding region of the START domain to residues 83–140 and revealed differential binding behavior versus STARD3, refining the structural basis of sterol recognition.","evidence":"Photoaffinity labeling with [3H]azocholestanol, peptide mapping, trypsin protection assays","pmids":["18331352"],"confidence":"Medium","gaps":["Atomic-resolution cholesterol-bound structure not solved","Functional consequence of differential trypsin protection unclear"]},{"year":2009,"claim":"Provided solution-state structural evidence for a two-state gating model in which C-terminal helix unfolding permits cholesterol entry followed by refolding.","evidence":"Solution-state NMR (1H-15N-HSQC), homology modeling, structure-based thermodynamics","pmids":["19138724"],"confidence":"Low","gaps":["Full structure not solved and no mutagenesis validation in this study","Single lab"]},{"year":2014,"claim":"Extended phosphoregulation of StAR by showing ERK1/2 phosphorylation and mitochondrial fusion control StAR retention on the outer membrane and thereby its activity.","evidence":"Phosphorylation assays, kinase inhibitor experiments, mitochondrial fractionation and steroidogenesis assays","pmids":["25540920"],"confidence":"Medium","gaps":["ERK phosphosite(s) not precisely mapped here","Mechanism linking fusion to retention unresolved"]},{"year":2017,"claim":"Identified post-transcriptional control of StAR by the H19/let-7 axis, adding a non-coding RNA layer to StAR regulation.","evidence":"H19 and let-7 overexpression with reporter assays in murine and human cell lines","pmids":["27813675"],"confidence":"Medium","gaps":["Physiological contexts where this axis dominates not defined","Single lab"]},{"year":2017,"claim":"Revealed a hepatic metabolic role: StAR overexpression reduces hepatic lipid accumulation and insulin resistance via FXR activation and reduced DAG/PKCε signaling, extending StAR function beyond steroidogenesis.","evidence":"Adenoviral StAR overexpression in HFD mice and FFA-overloaded hepatocytes with FXR inhibition rescue","pmids":["28153708"],"confidence":"Medium","gaps":["Mechanism linking StAR cholesterol transfer to FXR ligand generation not fully defined","Gain-of-function only"]},{"year":2019,"claim":"Established STARD1 as a driver of hepatotoxicity, where ER-stress-induced STARD1 loads mitochondrial cholesterol and depletes GSH upstream of SAB/JNK in acetaminophen-induced liver failure.","evidence":"Liver-specific conditional KO of Stard1, Sab and Jnk1/2 with epistasis, humanized liver mouse model, mitochondrial assays","pmids":["31029706"],"confidence":"High","gaps":["Direct mechanism of mitochondrial GSH depletion by cholesterol not fully resolved","How ER stress induces STARD1 transcription not defined here"]},{"year":2019,"claim":"Demonstrated direct HIF-1 binding and repression of the STAR promoter, providing a hypoxia-responsive brake on cholesterol transport and testosterone synthesis distinct from effects on other steroidogenic enzymes.","evidence":"ChIP, EMSA supershift, reporter assays with binding-site mutation, in vivo and in vitro hypoxia in Leydig/TM3 cells","pmids":["30400066"],"confidence":"High","gaps":["Interplay between HIF-1 repression and SF-1/CREB activation not integrated","Physiological hypoxia thresholds not defined"]},{"year":2021,"claim":"Linked STARD1-dependent cholesterol transfer to primary bile acid synthesis via the alternative mitochondrial pathway and to NASH-driven hepatocellular carcinoma through bile-acid effects on tumor-initiating cells.","evidence":"Hepatocyte-specific Stard1 deletion and overexpression in NASH-HCC mouse models, bile acid mass spectrometry, TIC assays","pmids":["33515644"],"confidence":"High","gaps":["Receptor mediating bile-acid effects on stemness not defined","Translation to human HCC not established"]},{"year":2021,"claim":"Confirmed STAR requirement for steroidogenesis in a clean knockout and uncovered a cholesterol-transport-independent role in lipid droplet diacylglycerol accumulation.","evidence":"CRISPR/Cas9 STAR knockout in MA-10 cells with steroidogenesis assays, EM, lipid-droplet LC-MS lipidomics and transcriptomics","pmids":["33670702"],"confidence":"Medium","gaps":["Mechanism of StAR influence on DAG metabolism unknown","Whether DAG role is direct or secondary unresolved"]},{"year":2021,"claim":"Identified acid ceramidase as an inverse regulator of STARD1 expression in Niemann-Pick C disease, connecting STARD1-driven mitochondrial cholesterol loading to lysosomal storage pathology via LRH-1.","evidence":"U18666A treatment in Stard1 mice, ACDase transfection in NPC patient fibroblasts, mitochondrial cholesterol/GSH and function assays","pmids":["34175669"],"confidence":"Medium","gaps":["Direct transcriptional mechanism via LRH-1 not fully mapped","Single lab across mixed model systems"]},{"year":null,"claim":"How StAR physically delivers cholesterol across the intermembrane space and the atomic structure of the cholesterol-loaded, membrane-engaged state remain unresolved, as does the molecular basis of its non-steroidogenic lipid metabolic roles.","evidence":"No single study in the timeline reconstitutes the complete transfer pathway or solves the membrane-bound holo structure","pmids":[],"confidence":"Low","gaps":["No full atomic structure of the membrane-engaged holo state","Mechanism of intermembrane cholesterol handoff not reconstituted","Mechanistic basis of DAG/lipid-droplet roles unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[1,5,10,11]},{"term_id":"GO:0140104","term_label":"molecular carrier activity","supporting_discovery_ids":[0,1]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,5,9]},{"term_id":"GO:0005811","term_label":"lipid droplet","supporting_discovery_ids":[17]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,14,19]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,7,12,20]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[3,12,15]}],"complexes":[],"partners":["TSPO","PAP7","PRKAR1A"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P25092","full_name":"Guanylyl cyclase C","aliases":["Heat-stable enterotoxin receptor","STA receptor","hSTAR","Intestinal guanylate cyclase"],"length_aa":1073,"mass_kda":123.4,"function":"Guanylyl cyclase that catalyzes synthesis of cyclic GMP (cGMP) from GTP (PubMed:11950846, PubMed:1718270, PubMed:22436048, PubMed:22521417, PubMed:23269669). Receptor for the E.coli heat-stable enterotoxin; E.coli enterotoxin markedly stimulates the accumulation of cGMP in mammalian cells expressing GUCY2C (PubMed:1680854, PubMed:1718270). Also activated by the endogenous peptides guanylin and uroguanylin (PubMed:8381596)","subcellular_location":"Cell membrane; Endoplasmic reticulum membrane","url":"https://www.uniprot.org/uniprotkb/P25092/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/STAR","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/STAR","total_profiled":1310},"omim":[{"mim_id":"620693","title":"ASTEROID HOMOLOG 1; ASTE1","url":"https://www.omim.org/entry/620693"},{"mim_id":"620064","title":"OXOEICOSANOID RECEPTOR 1; OXER1","url":"https://www.omim.org/entry/620064"},{"mim_id":"619747","title":"CARDIOMYOPATHY, DILATED, 2F; CMD2F","url":"https://www.omim.org/entry/619747"},{"mim_id":"618562","title":"TESTIS-EXPRESSED GENE 261; TEX261","url":"https://www.omim.org/entry/618562"},{"mim_id":"615209","title":"MICRO RNA 149; MIR149","url":"https://www.omim.org/entry/615209"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"adrenal gland","ntpm":3979.9}],"url":"https://www.proteinatlas.org/search/STAR"},"hgnc":{"alias_symbol":["STARD1"],"prev_symbol":[]},"alphafold":{"accession":"P25092","domains":[{"cath_id":"3.40.50.2300","chopping":"31-140_311-365","consensus_level":"high","plddt":78.2742,"start":31,"end":365},{"cath_id":"3.40.50.2300","chopping":"165-304_378-419","consensus_level":"high","plddt":88.5412,"start":165,"end":419},{"cath_id":"3.30.200.20","chopping":"474-485_498-564","consensus_level":"medium","plddt":77.9195,"start":474,"end":564},{"cath_id":"1.10.510.10","chopping":"565-779","consensus_level":"medium","plddt":83.2551,"start":565,"end":779},{"cath_id":"3.30.70.1230","chopping":"802-1041","consensus_level":"high","plddt":86.5315,"start":802,"end":1041}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P25092","model_url":"https://alphafold.ebi.ac.uk/files/AF-P25092-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P25092-F1-predicted_aligned_error_v6.png","plddt_mean":80.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=STAR","jax_strain_url":"https://www.jax.org/strain/search?query=STAR"},"sequence":{"accession":"P25092","fasta_url":"https://rest.uniprot.org/uniprotkb/P25092.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P25092/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P25092"}},"corpus_meta":[{"pmid":"23104886","id":"PMC_23104886","title":"STAR: ultrafast universal RNA-seq aligner.","date":"2012","source":"Bioinformatics (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/23104886","citation_count":38488,"is_preprint":false},{"pmid":"26052092","id":"PMC_26052092","title":"Circular RNA: A new star of noncoding RNAs.","date":"2015","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/26052092","citation_count":1436,"is_preprint":false},{"pmid":"26334920","id":"PMC_26334920","title":"Mapping RNA-seq Reads with STAR.","date":"2015","source":"Current protocols in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/26334920","citation_count":959,"is_preprint":false},{"pmid":"11181954","id":"PMC_11181954","title":"StAR protein and the regulation of steroid hormone biosynthesis.","date":"2001","source":"Annual review of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11181954","citation_count":694,"is_preprint":false},{"pmid":"17200706","id":"PMC_17200706","title":"The pancreatic stellate cell: a star on the rise in pancreatic diseases.","date":"2007","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/17200706","citation_count":582,"is_preprint":false},{"pmid":"31659415","id":"PMC_31659415","title":"CircRNA: a rising star in gastric cancer.","date":"2019","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/31659415","citation_count":326,"is_preprint":false},{"pmid":"34161407","id":"PMC_34161407","title":"Superoxide dismutase nanozymes: an emerging star for anti-oxidation.","date":"2021","source":"Journal of materials chemistry. B","url":"https://pubmed.ncbi.nlm.nih.gov/34161407","citation_count":295,"is_preprint":false},{"pmid":"24262661","id":"PMC_24262661","title":"MiR-200, a new star miRNA in human cancer.","date":"2013","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/24262661","citation_count":289,"is_preprint":false},{"pmid":"34692704","id":"PMC_34692704","title":"Exosomes, a New Star for Targeted Delivery.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/34692704","citation_count":280,"is_preprint":false},{"pmid":"33189359","id":"PMC_33189359","title":"Extracellular vesicles: A bright star of nanomedicine.","date":"2020","source":"Biomaterials","url":"https://pubmed.ncbi.nlm.nih.gov/33189359","citation_count":275,"is_preprint":false},{"pmid":"17433772","id":"PMC_17433772","title":"Steroidogenic acute regulatory protein (StAR), a novel mitochondrial cholesterol transporter.","date":"2007","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/17433772","citation_count":241,"is_preprint":false},{"pmid":"16041388","id":"PMC_16041388","title":"Target RNA motif and target mRNAs of the Quaking STAR protein.","date":"2005","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16041388","citation_count":239,"is_preprint":false},{"pmid":"8573184","id":"PMC_8573184","title":"Role of the steroidogenic acute regulatory protein (StAR) in steroidogenesis.","date":"1996","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/8573184","citation_count":224,"is_preprint":false},{"pmid":"10694364","id":"PMC_10694364","title":"The role of the StAR protein in steroidogenesis: challenges for the future.","date":"2000","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/10694364","citation_count":219,"is_preprint":false},{"pmid":"37475025","id":"PMC_37475025","title":"Extracellular vesicles: a rising star for therapeutics and drug delivery.","date":"2023","source":"Journal of nanobiotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/37475025","citation_count":216,"is_preprint":false},{"pmid":"19491374","id":"PMC_19491374","title":"Transcriptional regulation of steroidogenic genes: STARD1, CYP11A1 and HSD3B.","date":"2009","source":"Experimental biology and medicine (Maywood, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/19491374","citation_count":215,"is_preprint":false},{"pmid":"25883951","id":"PMC_25883951","title":"PVT1: a rising star among oncogenic long noncoding RNAs.","date":"2015","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/25883951","citation_count":192,"is_preprint":false},{"pmid":"9756854","id":"PMC_9756854","title":"Steroidogenic acute regulatory protein (StAR) is a sterol transfer protein.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9756854","citation_count":180,"is_preprint":false},{"pmid":"27115637","id":"PMC_27115637","title":"Optimizing RNA-Seq Mapping with STAR.","date":"2016","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/27115637","citation_count":171,"is_preprint":false},{"pmid":"11111087","id":"PMC_11111087","title":"Steroidogenic acute regulatory protein (StAR) and the intramitochondrial translocation of cholesterol.","date":"2000","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/11111087","citation_count":155,"is_preprint":false},{"pmid":"11463850","id":"PMC_11463850","title":"Tracking the role of a star in the sky of the new millennium.","date":"2001","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/11463850","citation_count":148,"is_preprint":false},{"pmid":"33762437","id":"PMC_33762437","title":"Chimeric STAR receptors using TCR machinery mediate robust responses against solid tumors.","date":"2021","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33762437","citation_count":135,"is_preprint":false},{"pmid":"8923870","id":"PMC_8923870","title":"Expression of steroidogenic acute regulatory protein (StAR) in the human ovary.","date":"1996","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/8923870","citation_count":129,"is_preprint":false},{"pmid":"25405282","id":"PMC_25405282","title":"BTG2: a rising star of tumor suppressors (review).","date":"2014","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/25405282","citation_count":121,"is_preprint":false},{"pmid":"19433304","id":"PMC_19433304","title":"Hepatic stellate cell: a star cell in the liver.","date":"2009","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/19433304","citation_count":113,"is_preprint":false},{"pmid":"38130633","id":"PMC_38130633","title":"Circular RNA: A promising new star of vaccine.","date":"2023","source":"Journal of translational internal medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38130633","citation_count":113,"is_preprint":false},{"pmid":"31029706","id":"PMC_31029706","title":"Endoplasmic Reticulum Stress-Induced Upregulation of STARD1 Promotes Acetaminophen-Induced Acute Liver Failure.","date":"2019","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/31029706","citation_count":112,"is_preprint":false},{"pmid":"32342639","id":"PMC_32342639","title":"Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report.","date":"2020","source":"American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons","url":"https://pubmed.ncbi.nlm.nih.gov/32342639","citation_count":99,"is_preprint":false},{"pmid":"22751500","id":"PMC_22751500","title":"STAR RNA-binding protein Quaking suppresses cancer via stabilization of specific miRNA.","date":"2012","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/22751500","citation_count":98,"is_preprint":false},{"pmid":"10548884","id":"PMC_10548884","title":"The steroidogenic acute regulatory protein (StAR): a window into the complexities of intracellular cholesterol trafficking.","date":"1999","source":"Recent progress in hormone research","url":"https://pubmed.ncbi.nlm.nih.gov/10548884","citation_count":98,"is_preprint":false},{"pmid":"29967585","id":"PMC_29967585","title":"A Rising Star in Pancreatic Diseases: Pancreatic Stellate Cells.","date":"2018","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29967585","citation_count":97,"is_preprint":false},{"pmid":"10535969","id":"PMC_10535969","title":"The STAR protein QKI-6 is a translational repressor.","date":"1999","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10535969","citation_count":97,"is_preprint":false},{"pmid":"11064158","id":"PMC_11064158","title":"Conservation of steroidogenic acute regulatory (StAR) protein structure and expression in vertebrates.","date":"2000","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/11064158","citation_count":94,"is_preprint":false},{"pmid":"32841898","id":"PMC_32841898","title":"HDAC11: a rising star in epigenetics.","date":"2020","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/32841898","citation_count":92,"is_preprint":false},{"pmid":"26284139","id":"PMC_26284139","title":"Argonaute 2: A Novel Rising Star in Cancer Research.","date":"2015","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/26284139","citation_count":91,"is_preprint":false},{"pmid":"9029708","id":"PMC_9029708","title":"Regulation of expression of the steroidogenic acute regulatory protein (StAR) gene: a central role for steroidogenic factor 1.","date":"1997","source":"Steroids","url":"https://pubmed.ncbi.nlm.nih.gov/9029708","citation_count":90,"is_preprint":false},{"pmid":"36204568","id":"PMC_36204568","title":"NLRP3 inflammasome: The rising star in cardiovascular diseases.","date":"2022","source":"Frontiers in cardiovascular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36204568","citation_count":83,"is_preprint":false},{"pmid":"30126353","id":"PMC_30126353","title":"Circular RNA: new star, new hope in cancer.","date":"2018","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30126353","citation_count":82,"is_preprint":false},{"pmid":"23907612","id":"PMC_23907612","title":"A star is born: new insights into the mechanism of astrogenesis.","date":"2013","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/23907612","citation_count":81,"is_preprint":false},{"pmid":"15344917","id":"PMC_15344917","title":"Neurosteroids: the StAR protein in the brain.","date":"2004","source":"Journal of neuroendocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/15344917","citation_count":76,"is_preprint":false},{"pmid":"30611252","id":"PMC_30611252","title":"Circular RNAs: a rising star in respiratory diseases.","date":"2019","source":"Respiratory research","url":"https://pubmed.ncbi.nlm.nih.gov/30611252","citation_count":76,"is_preprint":false},{"pmid":"10411331","id":"PMC_10411331","title":"Transcriptional regulation of the StAR gene.","date":"1999","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/10411331","citation_count":76,"is_preprint":false},{"pmid":"33515644","id":"PMC_33515644","title":"STARD1 promotes NASH-driven HCC by sustaining the generation of bile acids through the alternative mitochondrial pathway.","date":"2021","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/33515644","citation_count":74,"is_preprint":false},{"pmid":"33015046","id":"PMC_33015046","title":"CircRNA Is a Rising Star in Researches of Ocular Diseases.","date":"2020","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/33015046","citation_count":72,"is_preprint":false},{"pmid":"9116128","id":"PMC_9116128","title":"A StAR search: implications in controlling steroidgenesis.","date":"1997","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/9116128","citation_count":72,"is_preprint":false},{"pmid":"11191081","id":"PMC_11191081","title":"Leydig cell aging: steroidogenic acute regulatory protein (StAR) and cholesterol side-chain cleavage enzyme.","date":"2001","source":"Journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/11191081","citation_count":71,"is_preprint":false},{"pmid":"19005240","id":"PMC_19005240","title":"Astrocyte, the star avatar: redefined.","date":"2008","source":"Journal of biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/19005240","citation_count":69,"is_preprint":false},{"pmid":"22244330","id":"PMC_22244330","title":"Star-PAP control of BIK expression and apoptosis is regulated by nuclear PIPKIα and PKCδ signaling.","date":"2012","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/22244330","citation_count":68,"is_preprint":false},{"pmid":"22201776","id":"PMC_22201776","title":"Gonadal transactivation of STARD1, CYP11A1 and HSD3B.","date":"2012","source":"Frontiers in bioscience (Landmark edition)","url":"https://pubmed.ncbi.nlm.nih.gov/22201776","citation_count":66,"is_preprint":false},{"pmid":"33670702","id":"PMC_33670702","title":"Role of Constitutive STAR in Leydig Cells.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33670702","citation_count":65,"is_preprint":false},{"pmid":"34439285","id":"PMC_34439285","title":"NK Cell Therapy: A Rising Star in Cancer Treatment.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/34439285","citation_count":64,"is_preprint":false},{"pmid":"26758068","id":"PMC_26758068","title":"Structural basis of RNA recognition and dimerization by the STAR proteins T-STAR and Sam68.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26758068","citation_count":60,"is_preprint":false},{"pmid":"15595951","id":"PMC_15595951","title":"The role of potential splicing factors including RBMY, RBMX, hnRNPG-T and STAR proteins in spermatogenesis.","date":"2004","source":"International journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/15595951","citation_count":60,"is_preprint":false},{"pmid":"32360843","id":"PMC_32360843","title":"LncRNA SNHG5: A new budding star in human cancers.","date":"2020","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/32360843","citation_count":58,"is_preprint":false},{"pmid":"25540920","id":"PMC_25540920","title":"The role of mitochondrial fusion and StAR phosphorylation in the regulation of StAR activity and steroidogenesis.","date":"2014","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/25540920","citation_count":58,"is_preprint":false},{"pmid":"12530641","id":"PMC_12530641","title":"PBR, StAR, and PKA: partners in cholesterol transport in steroidogenic cells.","date":"2002","source":"Endocrine research","url":"https://pubmed.ncbi.nlm.nih.gov/12530641","citation_count":56,"is_preprint":false},{"pmid":"27619342","id":"PMC_27619342","title":"Circular RNA: a new star in neurological diseases.","date":"2016","source":"The International journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/27619342","citation_count":53,"is_preprint":false},{"pmid":"31774607","id":"PMC_31774607","title":"LncRNA SNHG15: A new budding star in human cancers.","date":"2019","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/31774607","citation_count":51,"is_preprint":false},{"pmid":"23415713","id":"PMC_23415713","title":"Expression and roles of steroidogenic acute regulatory (StAR) protein in 'non-classical', extra-adrenal and extra-gonadal cells and tissues.","date":"2013","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/23415713","citation_count":50,"is_preprint":false},{"pmid":"27813675","id":"PMC_27813675","title":"The Steroidogenic Acute Regulatory Protein (StAR) Is Regulated by the H19/let-7 Axis.","date":"2017","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/27813675","citation_count":49,"is_preprint":false},{"pmid":"35883211","id":"PMC_35883211","title":"Extrachromosomal circular DNA (eccDNA): an emerging star in cancer.","date":"2022","source":"Biomarker research","url":"https://pubmed.ncbi.nlm.nih.gov/35883211","citation_count":48,"is_preprint":false},{"pmid":"37839502","id":"PMC_37839502","title":"β-cell neogenesis: A rising star to rescue diabetes mellitus.","date":"2023","source":"Journal of advanced research","url":"https://pubmed.ncbi.nlm.nih.gov/37839502","citation_count":44,"is_preprint":false},{"pmid":"18331352","id":"PMC_18331352","title":"Cholesterol interaction with the related steroidogenic acute regulatory lipid-transfer (START) domains of StAR (STARD1) and MLN64 (STARD3).","date":"2008","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/18331352","citation_count":43,"is_preprint":false},{"pmid":"35644325","id":"PMC_35644325","title":"CircRNA: a rising star in plant biology.","date":"2022","source":"Journal of genetics and genomics = Yi chuan xue bao","url":"https://pubmed.ncbi.nlm.nih.gov/35644325","citation_count":42,"is_preprint":false},{"pmid":"17207924","id":"PMC_17207924","title":"Mechanism of StAR's regulation of mitochondrial cholesterol import.","date":"2007","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/17207924","citation_count":42,"is_preprint":false},{"pmid":"22353143","id":"PMC_22353143","title":"Hyperbranched polymeric \"star vectors\" for effective DNA or siRNA delivery.","date":"2012","source":"Accounts of chemical research","url":"https://pubmed.ncbi.nlm.nih.gov/22353143","citation_count":41,"is_preprint":false},{"pmid":"10462417","id":"PMC_10462417","title":"Steroidogenic acute regulatory (StAR) protein: what's new?","date":"1999","source":"BioEssays : news and reviews in molecular, cellular and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10462417","citation_count":39,"is_preprint":false},{"pmid":"35623170","id":"PMC_35623170","title":"CircRNA: An emerging star in the progression of glioma.","date":"2022","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/35623170","citation_count":36,"is_preprint":false},{"pmid":"28751864","id":"PMC_28751864","title":"Exosomes: A Rising Star in Falling Hearts.","date":"2017","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/28751864","citation_count":36,"is_preprint":false},{"pmid":"23803323","id":"PMC_23803323","title":"Intact cluster and chordate-like expression of ParaHox genes in a sea star.","date":"2013","source":"BMC biology","url":"https://pubmed.ncbi.nlm.nih.gov/23803323","citation_count":36,"is_preprint":false},{"pmid":"32220951","id":"PMC_32220951","title":"Evaluation of STAR and Kallisto on Single Cell RNA-Seq Data Alignment.","date":"2020","source":"G3 (Bethesda, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/32220951","citation_count":35,"is_preprint":false},{"pmid":"38711066","id":"PMC_38711066","title":"Nanozyme as a rising star for metabolic disease management.","date":"2024","source":"Journal of nanobiotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/38711066","citation_count":35,"is_preprint":false},{"pmid":"25159606","id":"PMC_25159606","title":"Perylene-cored star-shaped polycations for fluorescent gene vectors and bioimaging.","date":"2014","source":"ACS applied materials & interfaces","url":"https://pubmed.ncbi.nlm.nih.gov/25159606","citation_count":35,"is_preprint":false},{"pmid":"39660139","id":"PMC_39660139","title":"Lactate: a rising star in tumors and inflammation.","date":"2024","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/39660139","citation_count":33,"is_preprint":false},{"pmid":"33310138","id":"PMC_33310138","title":"Sestrin 2, a potential star of antioxidant stress in cardiovascular diseases.","date":"2020","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33310138","citation_count":33,"is_preprint":false},{"pmid":"37578015","id":"PMC_37578015","title":"circRNA: a promising all-around star in the future.","date":"2023","source":"Epigenomics","url":"https://pubmed.ncbi.nlm.nih.gov/37578015","citation_count":32,"is_preprint":false},{"pmid":"17210223","id":"PMC_17210223","title":"Dephosphorylation of TORC initiates expression of the StAR gene.","date":"2007","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/17210223","citation_count":32,"is_preprint":false},{"pmid":"35577145","id":"PMC_35577145","title":"Dental Pulp Fibroblast: A Star Cell.","date":"2022","source":"Journal of endodontics","url":"https://pubmed.ncbi.nlm.nih.gov/35577145","citation_count":31,"is_preprint":false},{"pmid":"30207101","id":"PMC_30207101","title":"Checkpoint-inhibition in ovarian cancer: rising star or just a dream?","date":"2018","source":"Journal of gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/30207101","citation_count":31,"is_preprint":false},{"pmid":"33108697","id":"PMC_33108697","title":"Reassessing Sarcopenia in Hypertension: STAR and ACE Inhibitors Excel.","date":"2020","source":"International journal of clinical practice","url":"https://pubmed.ncbi.nlm.nih.gov/33108697","citation_count":31,"is_preprint":false},{"pmid":"35491511","id":"PMC_35491511","title":"A novel adoptive synthetic TCR and antigen receptor (STAR) T-Cell therapy for B-Cell acute lymphoblastic leukemia.","date":"2022","source":"American journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/35491511","citation_count":31,"is_preprint":false},{"pmid":"26508523","id":"PMC_26508523","title":"A-Raf: A new star of the family of raf kinases.","date":"2015","source":"Critical reviews in biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/26508523","citation_count":29,"is_preprint":false},{"pmid":"17218054","id":"PMC_17218054","title":"Turnover of StAR protein: roles for the proteasome and mitochondrial proteases.","date":"2007","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/17218054","citation_count":29,"is_preprint":false},{"pmid":"34175669","id":"PMC_34175669","title":"Acid ceramidase improves mitochondrial function and oxidative stress in Niemann-Pick type C disease by repressing STARD1 expression and mitochondrial cholesterol accumulation.","date":"2021","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/34175669","citation_count":28,"is_preprint":false},{"pmid":"21189683","id":"PMC_21189683","title":"The star family member QKI and cell signaling.","date":"2010","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/21189683","citation_count":28,"is_preprint":false},{"pmid":"30400066","id":"PMC_30400066","title":"HIF 1 inhibits STAR transcription and testosterone synthesis in murine Leydig cells.","date":"2019","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/30400066","citation_count":28,"is_preprint":false},{"pmid":"38128483","id":"PMC_38128483","title":"Startle: A star homoplasy approach for CRISPR-Cas9 lineage tracing.","date":"2023","source":"Cell systems","url":"https://pubmed.ncbi.nlm.nih.gov/38128483","citation_count":27,"is_preprint":false},{"pmid":"38465204","id":"PMC_38465204","title":"Extracellular Vesicles: A New Star for Gene Drug Delivery.","date":"2024","source":"International journal of nanomedicine","url":"https://pubmed.ncbi.nlm.nih.gov/38465204","citation_count":26,"is_preprint":false},{"pmid":"19272380","id":"PMC_19272380","title":"Differential regulation of the STARD1 subfamily of START lipid trafficking proteins in human macrophages.","date":"2009","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/19272380","citation_count":26,"is_preprint":false},{"pmid":"19138724","id":"PMC_19138724","title":"Toward the NMR structure of StAR.","date":"2008","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/19138724","citation_count":25,"is_preprint":false},{"pmid":"29691317","id":"PMC_29691317","title":"Cholesterol signaling in single cells: lessons from STAR and sm-FISH.","date":"2018","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/29691317","citation_count":25,"is_preprint":false},{"pmid":"33454367","id":"PMC_33454367","title":"Exosomal circRNAs: A new star in cancer.","date":"2021","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33454367","citation_count":25,"is_preprint":false},{"pmid":"29474638","id":"PMC_29474638","title":"STAR Chimeric Post for rapid detection of circular RNA and fusion transcripts.","date":"2018","source":"Bioinformatics (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/29474638","citation_count":24,"is_preprint":false},{"pmid":"27999527","id":"PMC_27999527","title":"ACTH Action on StAR Biology.","date":"2016","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/27999527","citation_count":23,"is_preprint":false},{"pmid":"19875495","id":"PMC_19875495","title":"Sam68: a new STAR in the male fertility firmament.","date":"2009","source":"Journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/19875495","citation_count":23,"is_preprint":false},{"pmid":"29970675","id":"PMC_29970675","title":"Triptolide: A new star for treating human malignancies.","date":"2018","source":"Journal of cancer research and therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/29970675","citation_count":23,"is_preprint":false},{"pmid":"31902793","id":"PMC_31902793","title":"STARD1 and NPC1 expression as pathological markers associated with astrogliosis in post-mortem brains from patients with Alzheimer's disease and Down syndrome.","date":"2020","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/31902793","citation_count":22,"is_preprint":false},{"pmid":"29534958","id":"PMC_29534958","title":"StAR protein and steroidogenic enzyme expressions in the rat Harderian gland.","date":"2018","source":"Comptes rendus biologies","url":"https://pubmed.ncbi.nlm.nih.gov/29534958","citation_count":22,"is_preprint":false},{"pmid":"28153708","id":"PMC_28153708","title":"Steroidogenic acute regulatory protein (StAR) overexpression attenuates HFD-induced hepatic steatosis and insulin resistance.","date":"2017","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/28153708","citation_count":22,"is_preprint":false},{"pmid":"21189682","id":"PMC_21189682","title":"STAR trek: An introduction to STAR family proteins and review of quaking (QKI).","date":"2010","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/21189682","citation_count":22,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":40565,"output_tokens":5669,"usd":0.103365,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":14280,"output_tokens":5769,"usd":0.107813,"stage2_stop_reason":"end_turn"},"total_usd":0.211178,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"StAR protein mediates the rate-limiting step in steroidogenesis by transferring cholesterol from the outer to the inner mitochondrial membrane, where the cholesterol side-chain cleavage enzyme (P450scc) converts it to pregnenolone. StAR acts exclusively on the outer mitochondrial membrane, and its import into mitochondria is not essential for activity but rather represents a means of inactivating it.\",\n      \"method\": \"Genetic analysis of congenital lipoid adrenal hyperplasia mutations, StAR null mouse phenotype, functional complementation in COS-1 cells, recombinant protein studies on isolated mitochondria\",\n      \"journal\": \"Annual review of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods across multiple labs: reconstitution in engineered cells, mutagenesis, genetic disease validation, null mouse model\",\n      \"pmids\": [\"11181954\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Recombinant StAR protein (lacking the N-terminal 62 aa mitochondrial targeting sequence) stimulates transfer of cholesterol and beta-sitosterol from liposomes to heat-treated mitochondria in a dose-, time-, and temperature-dependent manner, demonstrating sterol transfer activity. A non-functional StAR mutant did not promote sterol transfer. Unlike SCP2, StAR did not stimulate phosphatidylcholine transfer, indicating sterol selectivity.\",\n      \"method\": \"In vitro sterol transfer assay using recombinant proteins, liposomes, and heat-treated mitochondria; site-directed mutagenesis of non-functional StAR\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with recombinant protein, mutagenesis controls, and multiple substrates tested\",\n      \"pmids\": [\"9756854\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"StAR is a target for serine phosphorylation by protein kinase A (PKA) at S194/195 (mouse/human), and this phosphorylation is required for maximizing StAR steroidogenic activity. Import into mitochondria inactivates StAR; the C-terminus contains the functionally important domains for steroidogenic activity.\",\n      \"method\": \"Truncation mutations, site-directed mutagenesis, functional assays in steroidogenic cells, phosphorylation studies\",\n      \"journal\": \"Recent progress in hormone research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — mutagenesis of phosphorylation sites combined with functional steroidogenesis assays, replicated across multiple studies\",\n      \"pmids\": [\"10548884\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Steroidogenic factor 1 (SF-1) is required for StAR gene transcription. The human StAR promoter contains two cis elements (distal and proximal) governing basal and cAMP-regulated expression; the distal element is a high-affinity SF-1 binding site. Cotransfection of SF-1 allows StAR promoter function in BeWo cells that normally lack activity; deletion or mutation of either element substantially reduces SF-1-supported activity.\",\n      \"method\": \"Promoter-luciferase reporter assays, cotransfection with SF-1 expression plasmid, deletion and site-directed mutation of cis elements, gel shift / binding assays\",\n      \"journal\": \"Steroids\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — promoter deletion/mutation combined with cotransfection rescue, binding assays, multiple orthogonal methods\",\n      \"pmids\": [\"9029708\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"StAR mRNA and protein are expressed in the most steroidogenic compartments of the human ovary (theca of preovulatory follicles, luteinized granulosa and thecal cells). cAMP analog 8-Br-cAMP increases StAR mRNA by increasing StAR gene transcription (not mRNA stability). Phorbol myristate acetate (protein kinase C activator) antagonizes the cAMP stimulatory effect on StAR expression.\",\n      \"method\": \"In situ hybridization, Northern blot, nuclear run-on transcription assays, mRNA stability assays, promoter-luciferase transfection in granulosa-lutein cells\",\n      \"journal\": \"The Journal of clinical endocrinology and metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (transcription run-on, stability assay, reporter assay) in primary human cells\",\n      \"pmids\": [\"8923870\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"StAR's interaction with protonated phospholipid head groups on the outer mitochondrial membrane induces a molten globule conformational change required for its cholesterol transfer activity. StAR requires cholesterol binding and acts on the outer membrane. A model is proposed wherein StAR removes cholesterol from the cholesterol-binding domain of the peripheral benzodiazepine receptor (PBR) and delivers it to the inner mitochondrial membrane.\",\n      \"method\": \"Biophysical spectroscopy, molecular dynamics simulations, structure-function studies in synthetic and natural membranes\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — biophysical and simulation data from single lab, mechanistic model supported by multiple orthogonal methods but not fully reconstituted biochemically\",\n      \"pmids\": [\"17433772\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"StAR acts on the outer mitochondrial membrane, requires cholesterol binding, and requires a pH-dependent molten globule structural change for function. Functional interaction between StAR and PBR (peripheral benzodiazepine receptor) is indicated.\",\n      \"method\": \"Structure-function analysis, biophysical studies, outer membrane activity assays\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biophysical and functional assays from single lab\",\n      \"pmids\": [\"17207924\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"PBR (peripheral benzodiazepine receptor), StAR, and PKA cooperate in hormone-induced mitochondrial cholesterol transport. PAP7, a protein that interacts with both PBR and the PKA regulatory subunit RIα, is present in mitochondria of adrenal and gonadal cells; overexpression of PAP7 increases hormone-induced steroid production, and inhibition of PAP7 reduces it, indicating PAP7 bridges PKA to PBR-StAR complex.\",\n      \"method\": \"Antisense oligonucleotide knockdown, co-immunoprecipitation/protein interaction studies, overexpression, steroid production assays in MA-10 Leydig cells\",\n      \"journal\": \"Endocrine research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — reciprocal protein interaction and functional rescue data, but single lab with limited mechanistic resolution\",\n      \"pmids\": [\"12530641\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ERK1/2 phosphorylates StAR, and this phosphorylation regulates StAR retention on the outer mitochondrial membrane (OMM) and StAR activity. Mitochondrial fusion also plays a role in regulating StAR retention on the OMM, thereby modulating its steroidogenic activity.\",\n      \"method\": \"Phosphorylation assays, kinase inhibitor experiments, mitochondrial fractionation, functional steroidogenesis assays\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — phosphorylation and functional assays in single lab with multiple approaches\",\n      \"pmids\": [\"25540920\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Once synthesized on free polyribosomes, StAR preprotein either associates with the outer mitochondrial membrane to mediate cholesterol transfer, or is degraded by the proteasome. Upon mitochondrial import, StAR is subject to rapid turnover: one pool is degraded by matrix proteases shortly after import; a second pool undergoes slower degradation after translocation to the matrix face of the inner membrane. Proteasome inhibitors (MG132, clasto-lactacystin beta-lactone but not epoxomicin) can inhibit turnover of both cytoplasmic preprotein and intra-mitochondrial StAR.\",\n      \"method\": \"Proteasome inhibitor treatment, immuno-electron microscopy, pulse-chase protein turnover assays, mitochondrial fractionation\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (immuno-EM, fractionation, pharmacological inhibition) from single lab\",\n      \"pmids\": [\"17218054\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Photoaffinity labeling with [(3)H]azocholestanol predominantly labeled a 6.2 kDa fragment (amino acids 83-140) of STARD1-START, which contains residues proposed to interact with cholesterol in a hydrophobic cavity. Cholesterol preferentially interacts with one side wall of this cavity. By contrast, cholesterol had no protective effect against trypsin degradation of STARD1-START (unlike STARD3), suggesting differential cholesterol-binding properties between the two START domains.\",\n      \"method\": \"Photoaffinity labeling with radiolabeled azocholestanol, trypsin protection assays, peptide mapping\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — direct photoaffinity labeling and peptide mapping identify cholesterol-binding region, single lab\",\n      \"pmids\": [\"18331352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"NMR studies of StAR in apo- and holo-states at physiological pH show well-dispersed resonances with key spectral differences between states, consistent with a two-state model in which the C-terminal alpha-helix undergoes partial unfolding (molten globule transition) to allow cholesterol binding, followed by stabilization and refolding upon cholesterol binding. This structural gating mechanism is proposed for cholesterol access.\",\n      \"method\": \"Solution-state NMR ((1)H-(15)N-HSQC), homology modeling, structure-based thermodynamics\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 2 / Weak — NMR data consistent with model but full structure not solved; single lab, no mutagenesis validation in this paper\",\n      \"pmids\": [\"19138724\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"TORC (transducer of regulated CREB activity), a CREB coactivator, regulates StAR gene expression: dephosphorylated TORC is active and promotes StAR transcription. PKA phosphorylates CREB and simultaneously inhibits TORC kinases, leading to TORC dephosphorylation and activation. Staurosporine (kinase inhibitor) increases dephospho-TORC and induces StAR expression in Y1 adrenocortical cells.\",\n      \"method\": \"Pharmacological inhibition (staurosporine, KG501), reporter gene assays, phosphorylation analysis, expression studies in Y1 adrenocortical cells\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological and reporter assays with mechanistic logic linking PKA to TORC dephosphorylation and StAR transcription, single lab\",\n      \"pmids\": [\"17210223\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Endoplasmic reticulum (ER) stress induces STARD1 upregulation in hepatocytes, which mediates mitochondrial cholesterol accumulation, sustained mitochondrial GSH depletion, and mitochondrial dysfunction leading to acetaminophen-induced acute liver failure. Liver-specific STARD1 deletion (Stard1ΔHep) protected mice from APAP/VPA-induced ALF despite increased mitochondrial GSH and phosphorylated JNK. STARD1 acts upstream of SAB (SH3BP5) and JNK1/2 phosphorylation in this hepatotoxicity pathway.\",\n      \"method\": \"Liver-specific conditional knockout mice (Stard1ΔHep, SabΔHep, Jnk1+2ΔHep), pharmacological ER stress inhibition (TUDCA), histology, mitochondrial function assays, humanized liver mouse model (FRGN)\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO of multiple pathway components with epistasis analysis, replicated in humanized liver model, multiple orthogonal readouts\",\n      \"pmids\": [\"31029706\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"STARD1 promotes generation of primary bile acids (β-muricholic acid, cholic acid and their tauroconjugates) through the alternative mitochondrial pathway in hepatocytes. STARD1 overexpression in NASH mouse models increases liver tumor multiplicity, while hepatocyte-specific STARD1 deletion reduces tumor burden. The STARD1-generated bile acids act on tumor-initiated stem-like cells (TICs) to stimulate stemness, pluripotency and inflammation, linking STARD1 to HCC pathogenesis.\",\n      \"method\": \"Hepatocyte-specific STARD1 deletion (Stard1ΔHep) and overexpression in NASH-HCC mouse models, bile acid profiling by mass spectrometry, TIC and primary hepatocyte incubation assays\",\n      \"journal\": \"Journal of hepatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic gain- and loss-of-function in multiple mouse models, mass spectrometry quantification, cell-based functional validation\",\n      \"pmids\": [\"33515644\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HIF-1 (hypoxia-inducible factor 1) directly binds to the StAR/STAR promoter at three specific binding sites (-2082/-2078, -2064/-2060, -1910/-1906) and represses STAR transcription, leading to reduced cholesterol transport and decreased testosterone synthesis in Leydig cells. This was shown to specifically affect cholesterol transport (blocked by pregnenolone rescue but not cAMP), while other steroidogenic enzymes (3b-HSD, 17b-HSD, P450scc) were not significantly affected.\",\n      \"method\": \"ChIP, EMSA supershift, dual-luciferase reporter assay, site-directed mutation of HIF-1 binding sites, hypoxia exposure in vivo (mice) and in vitro (rat primary Leydig cells, TM3 cells)\",\n      \"journal\": \"Journal of molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — ChIP, EMSA, reporter assay with mutation analysis, in vivo and in vitro validation across multiple orthogonal methods\",\n      \"pmids\": [\"30400066\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"StAR is a novel target of the microRNA let-7, which inhibits StAR at the post-transcriptional level. The long noncoding RNA H19 stimulates StAR expression by sponging/antagonizing let-7, thereby relieving let-7-mediated repression of StAR.\",\n      \"method\": \"Overexpression of H19 and let-7, reporter assays, murine and human cell line experiments\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — overexpression and reporter assays in cell lines, single lab, two cell systems tested\",\n      \"pmids\": [\"27813675\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"STAR knockout in MA-10 mouse Leydig cells abolishes progesterone formation in response to dibutyryl-cAMP and TSPO drug ligands (but not to the membrane-permeable 22(R)-hydroxycholesterol). STAR KO cells show significantly altered lipid droplet density and composition, with marked increases in diacylglycerol (DAG, particularly DAG 38:1), cholesteryl ester, and phosphatidylcholine in lipid droplets, suggesting constitutive STAR has a role in DAG accumulation in lipid droplets beyond cholesterol transport.\",\n      \"method\": \"CRISPR/Cas9 STAR knockout in MA-10 cells, steroid production assays, electron microscopy, liquid chromatography-mass spectrometry of lipid droplet content, transcriptomic analysis\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with multiple orthogonal readouts (steroidogenesis, EM, lipidomics) in single lab\",\n      \"pmids\": [\"33670702\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Acid ceramidase (ACDase) inversely regulates STARD1 expression: reduced ACDase in NPC disease correlates with increased STARD1 and mitochondrial cholesterol. Transfection of ACDase in NPC patient fibroblasts decreased STARD1 expression and mitochondrial cholesterol accumulation, resulting in increased mitochondrial GSH, improved mitochondrial function, and decreased oxidative stress. The STARD1 upregulation in NPC is dissociated from ER stress and linked to LRH-1 levels.\",\n      \"method\": \"U18666A treatment in Stard1f/f and Stard1ΔHep mice, ACDase transfection in NPC patient fibroblasts, mitochondrial cholesterol measurement, GSH assay, mitochondrial functional assays\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic and rescue experiments with mechanistic readouts, single lab, multiple cell/model systems\",\n      \"pmids\": [\"34175669\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"StAR overexpression in a high-fat diet NAFLD mouse model reduced hepatic lipid accumulation and attenuated insulin resistance through activation of the farnesoid X receptor (FXR) and reduction of intracellular diacylglycerol levels with consequent decreased PKCε phosphorylation. FXR inactivation reversed these beneficial effects of StAR overexpression.\",\n      \"method\": \"Recombinant adenovirus-mediated StAR overexpression in HFD mice and FFA-overloaded hepatocytes, lipid measurement, insulin signaling assays, FXR inhibition experiments\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular basis of disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function with pathway rescue (FXR inhibition), in vivo and in vitro, single lab\",\n      \"pmids\": [\"28153708\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"ACTH activates StAR through the cAMP-PKA signaling pathway. PKA-dependent phosphorylation of StAR at S194/195 (mouse/human) is required for StAR function. The current model places StAR translation and phosphorylation at the outer mitochondrial membrane as the site of StAR action.\",\n      \"method\": \"Review/synthesis of mutagenesis and phosphorylation studies; the mechanistic conclusions are grounded in cited primary experimental work on PKA phosphorylation and site-directed mutants\",\n      \"journal\": \"Frontiers in neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — synthesizes established mutagenesis and signaling data, but this specific paper is a review rather than primary experimental work\",\n      \"pmids\": [\"27999527\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"STAR/STARD1 is a mitochondrial cholesterol transfer protein that acts on the outer mitochondrial membrane to facilitate the rate-limiting transport of cholesterol from the outer to the inner mitochondrial membrane for steroid hormone biosynthesis; it functions via a pH-dependent molten globule conformational change, requires PKA-mediated phosphorylation at S194/195 for maximal activity, is transcriptionally regulated by SF-1/NR5A, CREB/TORC, and HIF-1, post-transcriptionally regulated by the H19/let-7 axis, and has additional roles in hepatic bile acid synthesis, mitochondrial cholesterol homeostasis in liver disease, and diacylglycerol metabolism in Leydig cells.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"STAR (STARD1) mediates the rate-limiting step of steroidogenesis by transferring cholesterol from the outer to the inner mitochondrial membrane, where P450scc converts it to pregnenolone [#0]. It is a sterol-selective transfer protein: recombinant StAR moves cholesterol and beta-sitosterol—but not phosphatidylcholine—from liposomes to mitochondria, and a non-functional mutant fails to do so [#1]. StAR acts on the cytosolic face of the outer mitochondrial membrane, where interaction with protonated phospholipid head groups drives a pH-dependent molten-globule conformational transition; the partially unfolded C-terminal helix opens a hydrophobic cavity (residues ~83–140) that binds cholesterol [#5, #10, #11]. Import into the mitochondrial matrix terminates StAR activity and targets it for turnover by matrix proteases and the proteasome, so activity is intrinsically coupled to its residence at the outer membrane [#0, #9]. StAR function is gated by phosphorylation: PKA phosphorylates S194/195 downstream of ACTH/cAMP signaling to maximize steroidogenic activity, while ERK1/2 phosphorylation and mitochondrial fusion control StAR retention at the outer membrane [#2, #8, #20]. Cholesterol delivery is organized within an outer-membrane complex involving the peripheral benzodiazepine receptor (PBR/TSPO), with PAP7 bridging PKA (RIα) to the PBR-StAR machinery [#5, #7]. STAR transcription is controlled by SF-1/NR5A acting at the proximal and distal promoter elements and by cAMP-driven CREB/TORC signaling, and is directly repressed by HIF-1 under hypoxia, while the H19/let-7 axis tunes StAR post-transcriptionally [#3, #4, #12, #15, #16]. Beyond steroidogenesis, STARD1 governs mitochondrial cholesterol homeostasis in hepatocytes: it is induced by ER stress to drive mitochondrial cholesterol loading and GSH depletion in acetaminophen-induced liver failure [#13], supplies cholesterol for primary bile acid synthesis via the alternative pathway and thereby promotes NASH-driven hepatocarcinogenesis [#14], and also influences hepatic lipid metabolism and diacylglycerol accumulation [#17, #19]. Genetic analysis of congenital lipoid adrenal hyperplasia mutations and the StAR-null mouse established its essential role in steroid hormone biosynthesis [#0].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established that StAR expression is concentrated in the most steroidogenic cells and is controlled at the transcriptional level by cAMP, defining the regulatory logic of acute steroidogenesis.\",\n      \"evidence\": \"In situ hybridization, nuclear run-on and reporter assays in primary human ovarian/granulosa-lutein cells\",\n      \"pmids\": [\"8923870\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the transcription factors mediating cAMP responsiveness\", \"Did not address protein-level mechanism of cholesterol transfer\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Identified SF-1 as the transcription factor required for StAR promoter activity, providing the molecular link between steroidogenic cell identity and StAR expression.\",\n      \"evidence\": \"Promoter-luciferase reporter assays, SF-1 cotransfection rescue in BeWo cells, cis-element deletion/mutation and binding assays\",\n      \"pmids\": [\"9029708\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve how cAMP signaling converges on the promoter\", \"Other promoter regulators not characterized\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Demonstrated directly that StAR is a sterol-selective transfer protein, answering whether StAR itself moves cholesterol rather than merely regulating another carrier.\",\n      \"evidence\": \"In vitro sterol transfer assay with recombinant StAR, liposomes, heat-treated mitochondria, with a non-functional mutant control and phosphatidylcholine selectivity test\",\n      \"pmids\": [\"9756854\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the membrane on which StAR acts in cells\", \"Structural basis of cholesterol selectivity not resolved\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Showed PKA phosphorylation at S194/195 maximizes StAR activity and that mitochondrial import inactivates it, establishing that StAR acts before/at the outer membrane and is post-translationally gated.\",\n      \"evidence\": \"Truncation and site-directed mutagenesis with functional steroidogenesis and phosphorylation assays\",\n      \"pmids\": [\"10548884\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which phosphorylation enhances activity not defined\", \"Did not establish the structural change underlying activity\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Synthesized genetic and biochemical evidence to fix the canonical model: StAR mediates the rate-limiting outer-to-inner membrane cholesterol transfer feeding P450scc, validated by congenital lipoid adrenal hyperplasia and the null mouse.\",\n      \"evidence\": \"Congenital lipoid adrenal hyperplasia mutation analysis, StAR-null mouse phenotype, COS-1 complementation, recombinant protein on isolated mitochondria\",\n      \"pmids\": [\"11181954\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular machinery transferring cholesterol across the intermembrane space not fully defined\", \"Outer-membrane partner proteins not yet identified\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Placed StAR within an outer-membrane signaling-transport complex by showing PAP7 bridges PKA (RIα) to PBR, coupling hormone signaling to cholesterol import.\",\n      \"evidence\": \"Antisense knockdown, co-IP/interaction studies, overexpression and steroid assays in MA-10 Leydig cells\",\n      \"pmids\": [\"12530641\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct StAR-PBR physical contact not biochemically resolved\", \"Single lab, limited mechanistic resolution\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Defined the conformational mechanism of StAR action—a pH/phospholipid-induced molten-globule transition at the outer membrane required for cholesterol transfer, with a proposed StAR-PBR cholesterol handoff.\",\n      \"evidence\": \"Biophysical spectroscopy, molecular dynamics, structure-function studies in synthetic and natural membranes (two complementary studies)\",\n      \"pmids\": [\"17433772\", \"17207924\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Not reconstituted as a complete biochemical pathway\", \"Direct cholesterol transfer from PBR to inner membrane not demonstrated\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Resolved StAR turnover dynamics, showing the cytoplasmic preprotein partitions between outer-membrane activity and proteasomal/matrix-protease degradation, mechanistically explaining why import inactivates StAR.\",\n      \"evidence\": \"Proteasome inhibitor treatment, immuno-EM, pulse-chase turnover, mitochondrial fractionation\",\n      \"pmids\": [\"17218054\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"E3 ligase / degradation signal not identified\", \"Quantitative flux between active and degraded pools not defined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Connected cAMP signaling to StAR transcription beyond SF-1 by showing the CREB coactivator TORC is activated by PKA-driven dephosphorylation to promote StAR expression.\",\n      \"evidence\": \"Pharmacological inhibition, reporter assays and phosphorylation analysis in Y1 adrenocortical cells\",\n      \"pmids\": [\"17210223\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"TORC binding to the StAR promoter not directly mapped\", \"Single lab pharmacological approach\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Localized the cholesterol-binding region of the START domain to residues 83–140 and revealed differential binding behavior versus STARD3, refining the structural basis of sterol recognition.\",\n      \"evidence\": \"Photoaffinity labeling with [3H]azocholestanol, peptide mapping, trypsin protection assays\",\n      \"pmids\": [\"18331352\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Atomic-resolution cholesterol-bound structure not solved\", \"Functional consequence of differential trypsin protection unclear\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Provided solution-state structural evidence for a two-state gating model in which C-terminal helix unfolding permits cholesterol entry followed by refolding.\",\n      \"evidence\": \"Solution-state NMR (1H-15N-HSQC), homology modeling, structure-based thermodynamics\",\n      \"pmids\": [\"19138724\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Full structure not solved and no mutagenesis validation in this study\", \"Single lab\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Extended phosphoregulation of StAR by showing ERK1/2 phosphorylation and mitochondrial fusion control StAR retention on the outer membrane and thereby its activity.\",\n      \"evidence\": \"Phosphorylation assays, kinase inhibitor experiments, mitochondrial fractionation and steroidogenesis assays\",\n      \"pmids\": [\"25540920\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"ERK phosphosite(s) not precisely mapped here\", \"Mechanism linking fusion to retention unresolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identified post-transcriptional control of StAR by the H19/let-7 axis, adding a non-coding RNA layer to StAR regulation.\",\n      \"evidence\": \"H19 and let-7 overexpression with reporter assays in murine and human cell lines\",\n      \"pmids\": [\"27813675\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological contexts where this axis dominates not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Revealed a hepatic metabolic role: StAR overexpression reduces hepatic lipid accumulation and insulin resistance via FXR activation and reduced DAG/PKCε signaling, extending StAR function beyond steroidogenesis.\",\n      \"evidence\": \"Adenoviral StAR overexpression in HFD mice and FFA-overloaded hepatocytes with FXR inhibition rescue\",\n      \"pmids\": [\"28153708\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking StAR cholesterol transfer to FXR ligand generation not fully defined\", \"Gain-of-function only\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established STARD1 as a driver of hepatotoxicity, where ER-stress-induced STARD1 loads mitochondrial cholesterol and depletes GSH upstream of SAB/JNK in acetaminophen-induced liver failure.\",\n      \"evidence\": \"Liver-specific conditional KO of Stard1, Sab and Jnk1/2 with epistasis, humanized liver mouse model, mitochondrial assays\",\n      \"pmids\": [\"31029706\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct mechanism of mitochondrial GSH depletion by cholesterol not fully resolved\", \"How ER stress induces STARD1 transcription not defined here\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrated direct HIF-1 binding and repression of the STAR promoter, providing a hypoxia-responsive brake on cholesterol transport and testosterone synthesis distinct from effects on other steroidogenic enzymes.\",\n      \"evidence\": \"ChIP, EMSA supershift, reporter assays with binding-site mutation, in vivo and in vitro hypoxia in Leydig/TM3 cells\",\n      \"pmids\": [\"30400066\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interplay between HIF-1 repression and SF-1/CREB activation not integrated\", \"Physiological hypoxia thresholds not defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Linked STARD1-dependent cholesterol transfer to primary bile acid synthesis via the alternative mitochondrial pathway and to NASH-driven hepatocellular carcinoma through bile-acid effects on tumor-initiating cells.\",\n      \"evidence\": \"Hepatocyte-specific Stard1 deletion and overexpression in NASH-HCC mouse models, bile acid mass spectrometry, TIC assays\",\n      \"pmids\": [\"33515644\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor mediating bile-acid effects on stemness not defined\", \"Translation to human HCC not established\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Confirmed STAR requirement for steroidogenesis in a clean knockout and uncovered a cholesterol-transport-independent role in lipid droplet diacylglycerol accumulation.\",\n      \"evidence\": \"CRISPR/Cas9 STAR knockout in MA-10 cells with steroidogenesis assays, EM, lipid-droplet LC-MS lipidomics and transcriptomics\",\n      \"pmids\": [\"33670702\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of StAR influence on DAG metabolism unknown\", \"Whether DAG role is direct or secondary unresolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identified acid ceramidase as an inverse regulator of STARD1 expression in Niemann-Pick C disease, connecting STARD1-driven mitochondrial cholesterol loading to lysosomal storage pathology via LRH-1.\",\n      \"evidence\": \"U18666A treatment in Stard1 mice, ACDase transfection in NPC patient fibroblasts, mitochondrial cholesterol/GSH and function assays\",\n      \"pmids\": [\"34175669\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct transcriptional mechanism via LRH-1 not fully mapped\", \"Single lab across mixed model systems\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How StAR physically delivers cholesterol across the intermembrane space and the atomic structure of the cholesterol-loaded, membrane-engaged state remain unresolved, as does the molecular basis of its non-steroidogenic lipid metabolic roles.\",\n      \"evidence\": \"No single study in the timeline reconstitutes the complete transfer pathway or solves the membrane-bound holo structure\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No full atomic structure of the membrane-engaged holo state\", \"Mechanism of intermembrane cholesterol handoff not reconstituted\", \"Mechanistic basis of DAG/lipid-droplet roles unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [1, 5, 10, 11]},\n      {\"term_id\": \"GO:0140104\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 5, 9]},\n      {\"term_id\": \"GO:0005811\", \"supporting_discovery_ids\": [17]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 14, 19]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 7, 12, 20]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [3, 12, 15]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"TSPO\", \"PAP7\", \"PRKAR1A\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}